Lab Automation For In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 Lab Automation For In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Lab Automation For In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Lab Automation For In-Vitro Diagnostics Industry

The Lab Automation For In-Vitro Diagnostics Market is highly fragmented with the presence of major players like Cognex Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, and Agilent Technologies Inc. Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

  • August 2023 - Roche Diagnostics, the diagnostic business unit of F. Hoffmann-La Roche, and Japanese diagnostics company Sysmex have expanded their existing global business partnership agreement. As part of the updated framework, the companies reaffirm their commitment to their long-standing collaboration. 
  • May 2023 - Werfen signed a new long-term partnership agreement with Thermo Fisher Scientific for the global distribution of a TCAutomation laboratory automation system in the specialized field of Hemostasis Diagnostics. 

Lab Automation For In-Vitro Diagnostics Market Leaders

  1. Cognex Corporation

  2. Roche Holding AG

  3. Thermo Fisher Scientific Inc.

  4. Danaher Corporation

  5. Siemens Healthineers AG

*Disclaimer: Major Players sorted in no particular order

Lab Automation For In-Vitro Diagnostics Market Conc.jpg

Lab Automation for In-vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)